RhumbLine Advisers’s Skye Bioscience SKYE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-14,423
| Closed | -$22.9K | – | 4291 |
|
|
2025
Q1 | $22.9K | Sell |
14,423
-3,082
| -18% | -$4.9K | ﹤0.01% | 3718 |
|
|
2024
Q4 | $49.5K | Buy |
17,505
+664
| +4% | +$1.88K | ﹤0.01% | 3651 |
|
|
2024
Q3 | $65.8K | Sell |
16,841
-2,913
| -15% | -$11.4K | ﹤0.01% | 3629 |
|
|
2024
Q2 | $158K | Buy |
+19,754
| New | +$158K | ﹤0.01% | 3355 |
|